We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA has approved a label update to ...
Leqvio's label update allows its use as a first-line monotherapy for LDL-C reduction in hypercholesterolemia, reflecting strong PCSK9-targeting evidence. The update addresses an unmet need, as many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback